Table 1.
Thermal Iatencies to radiant heat
|
Ipsilateral paw |
Contralateral paw |
---|---|---|
NT-3 overexpression | ||
Wild type | 6.07 ± 0.58 | 7.39 ± 0.71 |
Low-OE myo/NT-3 | 7.35 ± 0.73 | 9.93 ± 1.1 |
High-OE myo/NT-3 | 7.12 ± 0.70 | 8.75 ± 1.3 |
Exogenous NT-3 treatment | ||
WT—no acid, untreated | 4.43 ± 0.40 | 4.51 ± 0.25 |
WT—saline treated (i.m.) | 5.01 ± 0.32 | 5.11 ± 0.41 |
WT—NT-3 treated (i.m.) | 4.45 ± 0.29 | 5.22 ± 0.57 |
Routes of administration | ||
WT—NT-3 treated (i.m.) | 3.96 ± 0.76 | 3.41 ± 0.58 |
WT—NT-3 treated (i.p.) | 3.40 ± 0.63 | 4.01 ± 0.46 |
WT—NT-3 treated (i.t.) |
4.00 ± 0.56 |
3.97 ± 0.68 |
Four weeks after acid injection, thermal responses were recorded from each paw as withdrawal latencies from a radiant heat source (seconds). In regard to NT-3 overexpression, wild-type (WT) mice were derived from litters within the myo/NT-3 colony. For exogenous treatments, wild-type CF-1 mice were purchased from Charles River. Comparisons were made between test groups using one-way ANOVA and Fisher's PLSD. No differences in thermal thresholds were observed among transgenic or NT-3-treated mice or by using different routes of NT-3 administration (p > 0.05). Data are plotted as means ± SEM.